CapsuleAntacid Anti-Ulcerent
Rabeprazole Sodium (Enteric Coated) + Cinitapride (Sustained Release) · Proton pump inhibitor and prokinetic benzamide combination
These capsules combine enteric-coated rabeprazole, a proton pump inhibitor, with sustained-release cinitapride, a prokinetic agent. They are used for acid reflux and functional dyspepsia. Supplied as a finished dosage form for pharmaceutical distribution.
Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.
01Specification
02Related